 |
인쇄하기
취소
|
LG Life Sciences won EPO patent for its SR-hGH formulation technology
LG Life Sciences said on December 17 that it won a European Patent Office (EPO) for a novel formulation technology applied to a sustained-release human growth hormone (SR-hGH).
The company noted it filed the patent application for the sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid on March 1988 and with the acquisition of such patent, LG Life Science...
The company noted it filed the patent application for the sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid on March 1988 and with the acquisition of such patent, LG Life Science...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.